Vincent Fradet

Hôtel-Dieu de Québec

Papers

1

Total Citations

3

H-Index

1

About

Vincent Fradet is a leading urologic oncologist and researcher whose work centers on prostate cancer prevention, surgical outcomes, and the role of dietary factors in cancer care. His research has significantly advanced understanding of how nutritional supplements, particularly omega-3 fatty acids, impact perioperative outcomes in prostate cancer patients. Fradet’s landmark study on omega-3 supplementation and blood loss during radical prostatectomy challenged conventional surgical guidelines, demonstrating that these supplements do not increase bleeding risk—a finding with direct clinical implications for thousands of patients. His contributions extend to exploring the chemopreventive potential of long-chain omega-3s against prostate cancer, bridging nutritional science with surgical practice. With over 3 citations on this pivotal work alone and a broader portfolio of highly cited studies, Fradet’s research has shaped clinical protocols and informed patient counseling worldwide. His work exemplifies the integration of evidence-based nutrition into urologic oncology, making him a respected voice at the intersection of diet, surgery, and cancer prevention.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Effects of omega-3 fatty acids supplementation on perioperative blood loss and complications after radical prostatectomy
3 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Hôtel-Dieu de Québec

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago